Neuronetics, Inc.
STIM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5% | 9.4% | 17.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 72.3% | 72.5% | 76.3% | 78.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -45.9% | -31.9% | -49% | -48.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -58.4% | -42.3% | -57% | -56.4% |
| EPS Diluted | -1.38 | -1.05 | -1.38 | -1.22 |
| % Growth | -31.4% | 23.9% | -13.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |